Parameter | Betamethasone (N = 35) | Dexamethasone (N = 33) | Prednisolone (N = 39) | P-Value* | |||
---|---|---|---|---|---|---|---|
Age (years) (mean ± SD) | 45.94 ± 12.11 | 45.21 ± 9.93 | 46.62 ± 11.84 | 0.873Θ | |||
Weight (Kg) (mean ± SD) | 78.39 ± 19.66 | 79.21 ± 15.58 | 78.95 ± 20.22 | 0.987Θ | |||
Height (cm) (mean ± SD) | 158.46 ± 8.97 | 160.17 ± 6.31 | 158.36 ± 8.04 | 0.647Θ | |||
Disease Duration (years) (mean ± SD) | 3.87 ± 2.53 | 4 ± 3.39 | 4.24 ± 5.04 | 0.928Θ | |||
Gender (No. of Females (%)) | 33 (94.29%) | 27 (81.8%) | 35 (89.74%) | 0.258â—Š | |||
BMI (No. > 30 Kg/m2(%)) | 17 (48.57%) | 19 (57.6%) | 22 (56.41%) | 0.714â—Š | |||
No. of Subjects with Smoking History (%) | 3 (8.57%) | 2 (6.1%) | 3 (7.7%) | 0.922â—Š | |||
No. of Hypertensive Subjects (%) | 7 (20%) | 5 (15.2%) | 6 (15.38%) | 0.829â—Š | |||
No. of Diabetic Subjects (%) | 6 (17.14%) | 4 (12.1%) | 9 (23.1%) | 0.477â—Š | |||
Number of patients with other comorbidities (%) | |||||||
Pulmonary hypertension (%) | 3 (8.6%) | 2 (6.1%) | 3 (7.7%) | 0.072â—Š | |||
Cardiac problems (%) | 1 (2.86%) | 1 (3.03%) | 4 (10.26%) | ||||
Cancer (%) | 2 (5.7%) | 1 (2.56%) | |||||
Rheumatoid arthritis (%) | 2 (5.7%) | ||||||
Hepatosplenomegaly (%) | 2 (5.7%) | ||||||
Others (%) | 2 (5.7%) | 2 (5.13%) |